NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Pharmedium’

30 January 2014

Baird Capital eyes 44x return from CD&R’s Pharmedium purchase

Pharmedium drugs Baird Capital reportedly stands to make a 44-times return on its investment in drug compounding business Pharmedium Healthcare through its sale to fellow buyout house Clayton Dubilier & Rice.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014